Adults living with Type 2 diabetes wanted – Cardiovascular event prevention study

January 13, 2023

Dr. Jean-Claude Tardif’s research team at the Montreal Heart Institute (MHI) is looking for people living with type 2 diabetes to participate in the COLCOT-T2D clinical study.

The purpose of the study

The purpose of this study is to determine if an anti-inflammatory agent (colchicine) and an anti-platelet agent (aspirin), combined or alone, can prevent cardiovascular events in type 2 diabetic patients who have never had a cardiovascular event.

The implication

Take the study medication daily, which is delivered to your home every 6 months. Follow-up is done by telephone or video contact, without hospital visits.

The duration

Between 36 and 54 months.

Inclusion criteria

  • Living with type 2 diabetes
  • Aged between 50 and 80
  • Have never suffered a cardiac event

For more information about the study or to participate: